Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer
Diane
The post Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer appeared first on ECOG-ACRIN Cancer Research Group .